Predictions
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€11.40
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
15.79%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€10.90
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
5.50%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
02.11.20
02.11.20
€8.00
04.11.21
04.11.21
-
16.11.20
16.11.20
Could be very worthwhile Investment >20% year
Bio-Techne Corp.
Start price
Target price
Perf. (%)
€13.38
01.11.20
01.11.20
-
04.11.21
04.11.21
100.00%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€89.88
30.10.20
30.10.20
-
04.11.21
04.11.21
7.35%
03.01.21
03.01.21
Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€371.00
29.10.20
29.10.20
-
04.11.21
04.11.21
8.65%
30.12.20
30.12.20
EBIT growth >5% per year expected
Very low/no dividend yield expected
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€406.60
22.10.20
22.10.20
€580.00
04.11.21
04.11.21
37.09%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€201.33
22.10.20
22.10.20
€216.67
04.11.21
04.11.21
4.35%
07.11.20
07.11.20
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Misonix Inc.
Start price
Target price
Perf. (%)
€10.30
21.10.20
21.10.20
€12.00
02.11.20
02.11.20
-7.28%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Hologic Inc.
Start price
Target price
Perf. (%)
€56.50
20.10.20
20.10.20
€60.00
04.11.21
04.11.21
-11.63%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€9.65
19.10.20
19.10.20
€12.00
02.11.20
02.11.20
12.95%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€12.20
19.10.20
19.10.20
€15.00
02.11.20
02.11.20
-6.56%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€16.30
19.10.20
19.10.20
€20.00
02.11.20
02.11.20
-0.61%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
19.10.20
19.10.20
€10.00
02.11.20
02.11.20
-
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€12.90
17.10.20
17.10.20
-
04.11.21
04.11.21
-29.07%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
Bastide Le Confort
Start price
Target price
Perf. (%)
€45.70
11.10.20
11.10.20
€48.00
04.11.21
04.11.21
-7.11%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
QuidelOrtho Corp.
Start price
Target price
Perf. (%)
€212.00
06.10.20
06.10.20
-
04.11.21
04.11.21
-44.10%
05.11.21
05.11.21
Innovative
Higher risks for its business
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.70
05.10.20
05.10.20
€15.00
19.10.20
19.10.20
-17.52%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€10.70
05.10.20
05.10.20
€13.00
19.10.20
19.10.20
14.02%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€15.70
05.10.20
05.10.20
€20.00
19.10.20
19.10.20
3.82%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
05.10.20
05.10.20
€1.00
19.10.20
19.10.20
-
19.10.20
19.10.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.45
23.09.20
23.09.20
-
04.11.21
04.11.21
-47.51%
15.07.21
15.07.21
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.90
22.09.20
22.09.20
-
04.11.21
04.11.21
-49.70%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
21.09.20
21.09.20
-
28.09.20
28.09.20
40.54%
28.09.20
28.09.20
Risky Investment